Cancer survival in China, 2003-2005: A population-based study

International Journal of Cancer

Volumn 136, Issue 8, 2015, Pages 1921-1930

  Zeng, Hongmei ^a   Zheng, Rongshou ^a   Guo, Yuming ^b   Zhang, Siwei ^a   Zou, Xiaonong ^a   Wang, Ning ^c   Zhang, Limei ^d   Tang, Jingao ^e   Chen, Jianguo ^f   Wei, Kuangrong ^g   Huang, Suqin ^h   Wang, Jian ⁱ   Yu, Liang ^j   Zhao, Deli ^k   Song, Guohui ^l   Chen, Jianshun ^m   Shen, Yongzhou ⁿ   Yang, Xiaoping ⁱ   Gu, Xiaoping ^o   Jin, Feng ⁱ   Li, Qilong ^p   Li, Yanhua ^q   Ge, Hengming ^r   Zhu, Fengdong ⁱ   Dong, Jianmei ⁱ   Guo, Guoping ^s   Wu, Ming ^t   Du, Lingbin ^u   Sun, Xibin ^v   He, Yutong ^w   Coleman, Michel P ^x   Baade, Peter ^y   Chen, Wanqing ^a   Yu, Xue Qin ^z   more..

^a National Cancer Center   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^d Dalian Center for Disease Control and Prevention   (China)

^e Haimen Cancer Registry Haimen Center for Disease Control and Prevention   (China)

^f QIDONG LIVER CANCER INSTITUTE   (China)

^g ZHONGSHAN PEOPLE S HOSPITAL   (China)

^h Taixing Cancer Registry Taixing Center for Disease Control and Prevention   (China)

ⁱ Zhenjiang Center for Disease Control and Prevention   (China)

^j Linzhou Cancer Hospital   (China)

^k Feicheng People's Hospital in Shandong Province   (China)

^l Cixian Cancer Registry Cixian Institute for Cancer Prevention and Control   (China)

^m Changle Cancer Registry Changle Institute for Cancer Prevention and Control   (China)

ⁿ Haining Cancer Registry Haining Institute for Cancer Prevention and Control   (China)

^o Dafeng Cancer Registry Dafeng Center for Disease Control and Prevention   (China)

^p Jiashan Cancer Registry Jiashan Institute for Cancer Prevention and Control   (China)

^q Sihui Institute for Cancer Prevention and Control   (China)

^r Donghai Cancer Registry Donghai Center for Disease Control and Prevention   (China)

^s Yangzhong Cancer Registry Yangzhong Center for Disease Control and Prevention   (China)

^t JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^u ZHEJIANG CANCER HOSPITAL   (China)

^v University and Henan Cancer Hospital   (China)

^w HEBEI MEDICAL UNIVERSITY   (China)

^x LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^y CANCER COUNCIL QUEENSLAND   (Australia)

^z CANCER RESEARCH DIVISION   (Australia)

more..

Author keywords

Cancer registry; China; Geographical disparity; Population based study; Relative survival

Indexed keywords

ADOLESCENT; ADULT; AGED; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHINA; COLORECTAL CANCER; DISEASE SURVEILLANCE; ESOPHAGUS CANCER; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HUMAN; INFANT; INVESTMENT; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUTH CANCER; NASOPHARYNX CANCER; NEWBORN; POPULATION RESEARCH; REVIEW; RURAL AREA; STOMACH CANCER; SURVIVAL RATE; TREND STUDY; URBAN AREA; UTERINE CERVIX CANCER; VERY ELDERLY; AGE DISTRIBUTION; INCIDENCE; NEOPLASMS; PRESCHOOL CHILD; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84922632963     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29227     Document Type: Review

References (42)

1. Chen Z. The Third National Retrospective Sampling Survey on Causes of Death. ed. Beijing: Peking Union Medical College Press, 2008.
2. Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 2014;15:489-538.
3. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
4. Cancer Registry of Norway. Survival of cancer patients: Cases diagnosed in Norway 1968-1976 ed. Oslo: Norwegian Cancer Society, 1980.
5. Black RJ, Sharp L, Kendrick SW. Trends in cancer survival in Scotland 1968-90 ed.: Common Services Agency for the Scottish Health Service, Information & Statistics Division, Edinburgh, 1993.
6. Cutler SJ. International symposium on end results of cancer therapy. Computation of survival rates. Natl Cancer Inst Monogr 1964;15:381-5.
7. Kachuri L, De P, Ellison LF, Semenciw R. Cancer incidence, mortality and survival trends in Canada, 1970-2007. Chronic Dis Inj Can 2013;33:69-80.
8. Taylor R, Davis P, Boyages J. Long-term survival of women with breast cancer in New South Wales. Eur J Cancer 2003;39:215-22.
9. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730-56.
10. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. Lancet Oncol 2014;15:23-34.
11. Wang QJ, Zhu WX, Xing XM. Analysis of the incidence and survival of female breast cancer in Beijing during the last 20 years. Zhonghua Zhong Liu Za Zhi 2006;28:208-10.
12. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010;11:165-73.
13. Ferlay J, Burkhard C, Whelan S, Parkin DM. Check and conversion programs for cancer registries. (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42, 2005.
14. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computation, technical, end results evaluation sectioned. Bethesda, MD: National Cancer Institute, 1959.
15. Elandt-Johnson RC, Johnson NL. Survival models and data analysis (Wiley series in probability and mathematical statistics). Indianapolis: Wiley, 1980.
16. Micheli A, Baili P, Quinn M, et al. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol 2003;14(Suppl 5):v28-40.
17. Greenwood M. The natural duration of cancer. ed. London: HMSO, 1926.
18. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307-16.
19. National Bureau of Statistics of the People's Republic of China. Beijing, 2014. Available at http://www.stats.gov. cn/tjsj/tjbz/(accessed on April 1, 2014).
20. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51-64.
21. Dickman P, Coviello E, Hills M. Estimating and modeling relative survival. Stata J 2012;2012:1-23.
22. Australian Institute of Health and Welfare. Cancer Survival and Prevalence in Australia: Period Estimates from 1982 to 2010 ed. Canberra: AIHW, 2012.
23. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. Bethesda: National Cancer Institute, 2013.
24. Autier P, Boniol M, Hery C, et al. Cancer survival statistics should be viewed with caution. Lancet Oncol 2007;8:1050-2; author reply 3-4.
25. Gatta G, Capocaccia R, Sant M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47:533-8.
26. Fan L, Strasser-Weippl K, Li JJ, et al. Breast cancer in China. Lancet Oncol 2014;15:e279-89.
27. Anand S, Fan VY, Zhang J, et al. China's human resources for health: quantity, quality, and distribution. Lancet 2008;372:1774-81.
28. Wang G, Xu H, Jiang M. Evaluation on comprehensive quality of 456 doctors in township hospitals. J Health Resour 2003;6:72-4.
29. Liu M, Zhang Q, Lu M, et al. Rural and urban disparity in health services utilization in China. Med Care 2007;45:767-74.
30. Chen W, Armstrong BK, Zheng R, et al. Cancer burden in China: a Bayesian approach. BMC Cancer 2013;13:458.
31. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013;368:351-64.
32. Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006;28:112-25.
33. Li C, Yu X, Butler JR, et al. Moving towards universal health insurance in China: performance, issues and lessons from Thailand. Soc Sci Med 2011;73:359-66.
34. Sankaranarayanan R, Black RJ, Swaminathan R, Parkin DM. An overview of cancer survival in developing countries. IARC Sci Publ 1998:135-73.
35. Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ 2011:257-91.
36. Berrino F. The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol 2003;14(Suppl 5):v9-13.
37. Brenner H, Hakulinen T. Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries. Int J Cancer 2009;125:432-7.
38. Yang G, Hu J, Rao KQ, et al. Mortality registration and surveillance in China: history, current situation and challenges. Popul Health Metr 2005;3:3.
39. Yang L, Wang N, Zhu WX, et al. The analysis of the active follow-up study of registered cancer patients between 2002 and 2005 in urban areas of Beijing. Zhonghua Yu Fang Yi Xue Za Zhi 2012;46:604-6.
40. Merrill RM, Dearden KA. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control 2004;15:1027-34.
41. Allemani C, Sant M, Weir HK, et al. Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer 2013;132:1170-81.
42. Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer 2013;108:1195-208.